Regulation of FasL expression in natural killer cells

Human Immunology

Volumn 65, Issue 4, 2004, Pages 317-327

  Chua, Hui Lin ^a   Serov, Youri ^a   Brahmi, Zacharie ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; CD94 ANTIGEN; FAS LIGAND; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ARTICLE; CYTOTOXICITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA EXTRACTION;

ANTIGENS, CD; ANTIGENS, CD95; CYTOTOXICITY, IMMUNOLOGIC; DNA FINGERPRINTING; DNA FRAGMENTATION; FAS LIGAND PROTEIN; FLOW CYTOMETRY; HLA-A ANTIGENS; HUMANS; INTERLEUKIN-2; JURKAT CELLS; KILLER CELLS, LYMPHOKINE-ACTIVATED; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MEMBRANE GLYCOPROTEINS; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER; UP-REGULATION;

EID: 2142678118     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2004.01.004     Document Type: Article

References (56)

1. Lanier L.L. NK cell receptors. Ann Rev Immunol. 16:1998;359
2. Lanier L.L. Turning on natural killer cells. J Exp Med. 191:2000;1259
3. Bottino C., Biassom R., Millo R., Moretta A., Moretta L. The human natural cytotoxicity receptors (NCR) that induce HLA class I-independent NK cell triggering. Hum Immunol. 61:2000;1
4. Kärre K., Ljunggren H.-G., Piontek G., Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature. 319:1986;675
5. Ljunggren H.-G., Kärre K. In search of the "missing-self:" MHC molecules and NK cell recognition. Immunol Today. 11:1990;237
6. Trinchieri G. Biology of natural killer cells. Adv Immunol. 47:1989;187
7. Kägi D., Vignaux F., Ledermann B., Bürki K., Depraetere V., Nagata S., Hengartner H., Golstein P. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science. 265:1994;528
8. Montel A.H., Bochan M.R., Hobbs J.A., Lynch D.H., Brahmi Z. Fas involvement in cytotoxicity mediated by human NK cells. Cell Immunol. 166:1995;236
9. Eischen C.M., Liebson P.J. Role of NK-cell-associated Fas ligand in cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis. Res Immunol. 148:1997;164
10. Ashkenazi A., Dixit V. Death receptors signaling and modulation. Science. 281:1998;1305
11. Froelich C.J., Dixit V.M., Yang X. Lymphocyte granule-mediated apoptosis matters of viral mimicry and deadly proteases. Immunol Today. 19:1998;30
12. Smyth M.J., Trapani J.A. Granzymes exogenous proteinases that induce target cell apoptosis. Immunol Today. 16:1995;202
13. Steller H. Artificial death switches Induction of apoptosis by chemically induced caspase multimerization. Proc Natl Acad Sci U S A. 95:1998;5421
14. Leithäuser F., Dhein J., Mechtersheimer G., Koretz K., Brüderlein S., Henne C., Schmidt A., Debatin K.-M., Krammer P.H., Möller P. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest. 69:1993;415
15. Lynch D.H., Ramsdell F., Alderson M.R. Fas and FasL in the homeostatic regulation of immune responses. Immunol Today. 16:1995;569
16. Ortaldo J.R., Mason A.T., O'Shea J.J. Receptor-induced death in human natural killer cells involvement of CD16. J Exp Med. 181:1995;339
17. Eischer C.M., Schilling J.D., Lynch D.H., Krammer P.H., Liebson P.J. Fe receptor-induced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis. J Immunol. 156:1996;2693
18. Rawadi G., Lecaque D., Pirot D., Roman-Roman S. Detection and identification of mycoplasma contamination in cell cultures by polymerase chain reaction. Meth Mol Cell Biol. 4:1993;147
19. lck activation. J Exp Med. 176:1992;1745
20. Matzinger P. The JAM test. A simple assay for DNA fragmentation and cell death. J Immunol Methods. 145:1991;185
21. Chua H.L., Brahmi Z. Expression of p58.2 or CD94/NKG2A inhibitory receptors in an NK-like cell line, YTINDY, leads to HLA class I-mediated inhibition of cytotoxicity in the p58.2- but not the CD94/NKG2A-expressing transfectant. Cell Immunol. 219:2002;57
22. Bossi G., Griffiths G.M. Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nature Med. 5:1999;90
23. Garner R., Helgason C.D., Atkinson E.A., Pinkoski M.J., Ostergaard H.L., Sorenson O., Fu A., Lapchak P.H., Rabinovitch A., McElhaney J.E., Berke G., Bleackley R.C. Characterization of a granule-independent lytic mechanism used by CTL hybridomas. J Immunol. 153:1994;5413
24. Walsh C.M., Glass A.A., Chiu V., Clark W.R. The role of the Fas lytic pathway in a perforin-less CTL hybridoma. J Immunol. 153:1994;2506
25. Aung S., Graham B.S. IL-4 diminishes perforin-mediated and increases Fas ligand-mediated cytotoxicity in vivo. J Immunol. 164:2000;3487
26. Hashimoto W., Osaki T., Okamura H., Robbins P.D., Kurimoto M., Nagata S., Lotze M.T., Tahara H. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis respectively. J Immunol. 163:1999;583
27. Kataoka T., Shinohara N., Takayama H., Takaku K., Kondo S., Yonehara S., Nagai K. Concanamycin A, a powerful tool for characterization and estimation of contribution of Perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. J Immunol. 156:1996;3678
28. Murphy W.J., Reynolds C.W., Tiberghien P., Longo D.L. Natural killer cells and bone marrow transplantation. J Natl Cancer Inst. 85:1993;1475
29. Dokhelar M.-C., Wiels J., Lipinski M., Tetaud C., Devergie A., Gluckman E., Tursz T. Natural killer cell activity in human bone marrow recipients. Early reappearance of peripheral natural killer activity in graft-versus-host disease. Transplantation. 31:1981;61
30. Vitale M., Falcol M., Castriconi R., Parolini S., Zambello R., Semenzato G., Biassoni R., Bottino C., Moretta L., Moretta A. Identification of NKp80, a novel triggering molecule expressed by human NK cells. Eur J Immunol. 31:2001;233
31. Brahmi Z., Hommel-Berrey G., Smith F., Thomson B. NK cells recover early and mediate cytotoxicity via perforin/granzyme Fas/FasL pathways in umbilical cord blood patients. Hum Immunol. 62:2001;782
32. Taylor M.A., Ward B., Schatzle J.D., Bennet M. Perforin- and Fas- dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts. Eur J Immunol. 7:2002;793
33. Kanda Y., Tanaka Y., Shirakawa K., Yatomi T., Nakamura N., Kami M., Saito T., Izutsu K., Asai T., Yuji K., Ogawa S., Honda H., Mitani K., Chiba S., Yazaki Y., Hirai H. Increased soluble Fas-ligand in sera of bone marrow transplant recipients with acute graft-versus-host disease. Bone Marrow Transplantation. 22:1998;751
34. Das H., Shion I., Murayama T., Kajimoto K., Sugimoto T., Isobe T., Nakagawa T., Nishimura R., Koizumi T. Levels of soluble FasL and FasL gene expression during the development of graft-versus-host disease in DLT-treated patients. B J Haematol. 104:1999;795
35. Tanaka M., Suda T., Haze K., Nakamura N., Sato K., Kimura F., Motoyoshi K., Mizuli M., Tagawal S., Ohga S., Hatake K., Drummond A.H., Nagata S. Fas ligand in human serum. Nature Med. 2:1996;317
36. Braud V., Jones E.Y., McMichael A. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur J Immunol. 27:1997;1164
37. Borrego F., Ulbrecht M., Weiss E.H., Coligan J.E., Brooks A.G. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med. 187:1998;813
38. Lee N., Llano M., Carretero M., Ishitani A., Navarro F., López-Boteu M., Geraghty D.E. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci U S A. 95:1998;5199
39. Binstad B.A., Brumbaugh K.M., Dick C.J., Scharenberg A.M., Williams B.L., Colonna M., Lanier L.L., Kinet J.-P., Abraham R.T., Liebson P.J. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity. 5:1996;629
40. Burshtyn D.N., Scharenberg A.M., Wagtman N., Rajagopalan S., Berrada K., Yi T., Kinet J.-P., Long E.O. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity. 4:1996;77
41. Palmieri G., Tullio V., Zingoni A., Piccoli M., Frati L., López-Botet M., Santoni A. CD94/NKG2-A inhibitory complex blocks CD16-triggered syk and extracellular regulated kinase activation, leading to cytotoxic function of human NK cells. J Immunol. 162:1999;7181
42. Chuang S.S., Kim M.H., Johnson L.A., Albertsson P., Kitson R.P., Nannmark U., Goldfarb R.H., Mathew P.A. 2B4 stimulation of YT cells induces natural killer cell cytolytic function and invasiveness. Immunology. 100:2000;378
43. Chuang S.S., Kumaresan P.R., Mathew P.A. 2B4 (CD244)-mediated activation of cytotoxicity and IFN-γ release in human NK cells involves distinct pathways. J Immunol. 167:2001;6210
44. Bottino C., Augugliaro R., Castriconi R., Nanni M., Biassoni R., Moretta L., Moretta A. Analysis of the molecular mechanism involved in 2B4-mediated NK cell activation evidence that human 2B4 is physically and functionally associated with the linker for activation of T cells. Eur J Immunol. 30:2000;3718
45. Watzl C., Stebbins C.C., Long E.O. NK cell inhibitory receptors prevent tyrosine phosphorylation of the activating receptor 2B4 (CD244). J Immunol. 165:2000;3545
46. Sivori S., Parolini S., Falco M., Marcenaro E., Biassoni R., Bottino C., Moretta L., Moretta A. 2B4 functions as a co-receptor in human NK cell activation. Eur J Immunol. 30:2000;787
47. 2+ in Fas ligand-induced lysis. J Immunol. 159:1997;3140
48. Zhou Y.-W., Komada Y., Inaba H., Deguchi T., Sugiyama K., Azuma E., Sakurai M. Functional significance of adhesion molecules in Fas-dependent apoptotic cell death induced by interleukin2-activated T cells. Immunol Invest. 27:1998;309
49. Timonen T., Patarroyo M., Gahmberg C.G. CD11a-c/CD18 and GP84 (LB-2) adhesion molecules on human large granular lymphocytes and their participation in natural killing. J Immunol. 141:1998;1041
50. Yokoyama S., Staunton D., Fisher R., Amiot M., Fortin J.J., Thorley-Lawson D.A. Expression of the BLAST-1 activation/adhesion molecule and its identification as CD48. J Immunol. 146:1991;2192
51. Brown M.H., Boles K., van der Merwe P.A., Kumar V., Mathew P.A., Barclay A.N. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J Exp Med. 188:1998;2083
52. Latchman Y., McKay P.F., Reiser H. Identification of the 2B4 molecule as a counter-receptor for CD48. J Immunol. 161:1998;5809
53. Nakajima H., Cella M., Langen H., Friedlein A., Colonna M. Activating interactions in human NK cell recognition the role of 2B4-CD48. Eur J Immunol. 29:1999;1676
54. Sayós J., Nguyen K.B., Wu C., Stepp S.E., Howie D., Schatzle J.D., Kumar V., Biron C.A., Terhorst C. Potential pathways for regulation of NK and T cell responses differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4. Int Immunol. 12:2000;1749
55. Tangye S.G., Lazetic S., Woollatt E., Sutherland G.R., Lanier L.L., Phillips J.H. Human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP2 and the adaptor signaling protein SAP. J Immunol. 162:1999;6981
56. Levitskaya J., Sharipo A., Leonchiks A., Ciechanover A., Masucci M.G. Inhibition of ubiquitin/proteosome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen-1. Proc Natl Acad Sci U S A. 94:1997;12616